EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

9 hedge funds and large institutions have $38.7K invested in Eagle Pharmaceuticals, Inc. in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.86K
2
+$579

Top Sellers

1
-$8.79M
2
-$4.52M
3
-$3.73M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.16M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$11.8K
2
$9K
3
$7K
4
$6K
5
$3K
6
$1.71K
7
$175
8
$18
9
$18
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2 3